ClinicalTrials.gg
Sign In

Eclampsia clinical trials

The registry lists 76 studies for Eclampsia across more than 10 countries. 13 are recruiting or about to start. 10 of them are mainly about Eclampsia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.

Get an email when these change. Save the Eclampsia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
43
Status unknown
10
Recruiting
10
Active, not recruiting
4
Not yet recruiting
3
Terminated
3

Phase

Phase 4
7
Phase 3
4
Phase 2
2
Phase 1
1

Where

United States
21
Pakistan
5
India
5
France
4
Nigeria
4
China
2

Who runs them

Aga Khan University (2) · University Tunis El Manar (2) · NICHD Global Network for Women's and Children's Health (2) · Centre Hospitalier Universitaire de Saint Etienne (2) · Gynuity Health Projects (2) · University of Alabama at Birmingham (2) · Cairo University (1) · Siriraj Hospital (1)

What is being tested here

Drugs under test in Eclampsia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cholecalciferol102
Levetiracetam111
Aspirin101
Magnesium Sulfate013
Labetalol012
Acetaminophen001
Methyldopa001
Calcium011
Ascorbic Acid011
Citrulline001

Coming up

1phase 3 study under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 10 Eclampsia studies recruiting now, 5 (50%) set no upper age limit and 5 (50%) stop at 75 or younger. 3 (30%) take children under 18. 9 (90%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
101 (10%)0 (0%)
1810 (100%)1 (10%)
3010 (100%)1 (10%)
4010 (100%)1 (10%)
509 (90%)1 (10%)
655 (50%)1 (10%)
755 (50%)1 (10%)
855 (50%)1 (10%)

Across all 76 studies, recruiting or not: 50% stop at 75 or younger and 50% at 65; 36% take children; 89% are for women only and 1% for men only; 43% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Eclampsia studies take

Of 19 observational studies under Eclampsia, half reached primary completion within 34 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational34 mo14–43 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 76. Browse all 76 → or search them.